Gates Foundation to spend $120M on access for COVID-19 pill

Visits: 6

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators Read More Go To Source